Robert Villareal
Family Medicine · Broken Arrow, OKNPI 1629046883
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 289 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,359 and has fallen 90.0% since, to $136 in 2025.
Across 289 payments — averaging $17.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$678
- Merck$572
- Novo Nordisk$451
- Lilly USA, LLC$412
- Boston Scientific$389
- GSK$297
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,956100%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 35 | $678 |
| Merck | 43 | $572 |
| Novo Nordisk | 29 | $451 |
| Lilly USA, LLC | 29 | $412 |
| Boston Scientific | 4 | $389 |
| GSK | 20 | $297 |
| AbbVie(2 entities) | 18 | $268 |
| Bayer | 11 | $265 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $210 |
| Johnson & Johnson | 13 | $191 |
| Amgen | 10 | $189 |
| Boehringer Ingelheim | 8 | $156 |
| Pfizer | 9 | $150 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $133 |
| Novartis | 6 | $112 |
| Eisai Inc. | 6 | $86 |
| Amarin Pharma, Inc. | 5 | $84 |
| Aytu Biopharma, Inc. | 5 | $68 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $39 |
| Astellas Pharma US Inc | 2 | $36 |
| Currax Pharmaceuticals LLC | 2 | $32 |
| Intra-sana Laboratories | 1 | $30 |
| Biohaven Pharmaceuticals, Inc. | 2 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Abbott | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Watchman$242
- WATCHMAN Access System$139
- FARXIGA$123
- Kerendia$121
How this compares
$4,973 in reported general payments places this provider in the 85th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Broken Arrow
- James CampbellBroken Arrow$35K
- Alexander FrankOklahoma City$3.1M
- Stanley ShadidEdmond$363K
- Geoffrey PlumleeTulsa$297K
- Curtis HarrisAda$125K
- Melinda CailOklahoma City$122K
- Jose Maria Borrego AcostaOklahoma City$106K
- Lisa ConneryNorman$105K
- Michael RobinsonElk City$84K
- Kimberly HuttonTulsa$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.